EUVIMEDEUVIMED entdecken
Open Access

KLF9 aggravates the cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy through the lncRNA UCA1 /p27 axis

Dayou Ding, Guangrong Zhao iD

International Journal of Experimental Pathology · 2025

DOI: 10.1111/iep.12526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Experimental Pathology, 2025. Verfasst von Dayou Ding und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Tianjin University, Tianjin, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Myocytes, Cardiac, Kruppel-Like Transcription Factors, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac hypertrophy refers to an abnormal increase in the thickness of the heart muscle. Our study explores the role of Krüppel‐like factor 9 (KLF9) in hypertrophic obstructive cardiomyopathy (HOCM)‐induced cardiomyocyte hypertrophy, providing new targets for the treatment of HOCM. Cardiomyocytes were treated with isoproterenol (ISO). The levels of natriuretic peptide B (BNP)/natriuretic peptide A (ANP)/KLF9/long non‐coding RNA urothelial carcinoma‐associated 1 (lncRNA UCA1)/p27 were measured. Cell surface area and protein/DNA ratio were tested. The binding between KLF9 and the lncRNA UCA1 promoter and between zeste homologue 2 (EZH2) and lncRNA UCA1 was verified. The enrichment of histone H3 lysine 27 tri‐methylation (H3K27me3) and EZH2 on the p27 promoter was analysed. ISO treatment increased KLF9 and lncRNA UCA1 expression and decreased p27 expression in cardiomyocytes. KLF9 knockdown inhibited ISO‐induced cardiomyocyte hypertrophy, reduced ANP and BNP expression, and alleviated cardiomyocyte damage. KLF9 activated lncRNA UCA1 expression. LncRNA UCA1 recruited EZH2 to the p27 promoter region, increasing the enrichment of H3K27me3, thereby epigenetically suppressing p27 expression. LncRNA UCA1 overexpression or p27 downregulation reduced the protective effect of KLF9 downregulation on cardiomyocyte hypertrophy. In conclusion, KLF9 activates lncRNA UCA1 expression, and lncRNA UCA1 epigenetically suppresses p27 expression, thereby exacerbating cardiomyocyte hypertrophy in HOCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingMyocytes, CardiacKruppel-Like Transcription FactorsCardiomyopathy, HypertrophicCyclin-Dependent Kinase Inhibitor p27CardiomegalyAnimalsEnhancer of Zeste Homolog 2 ProteinMaleHumansRatsRats, Sprague-DawleyIsoproterenol

Stichwörter der Autor:innen

EZH2HOCMKLF9LncRNA UCA1cardiomyocyte hypertrophy

Substanzen

RNA, Long NoncodingKruppel-Like Transcription FactorsEnhancer of Zeste Homolog 2 ProteinCyclin-Dependent Kinase Inhibitor p27UCA1 RNA, humanIsoproterenol

Autor:innen und Institutionen

  • School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.

ORCID-Profile: Guangrong Zhao

Zitieren

APA

Ding, D., & Zhao, G. (2025). KLF9 aggravates the cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy through the lncRNA UCA1 /p27 axis. International Journal of Experimental Pathology. https://doi.org/10.1111/iep.12526

Vancouver

Ding D, Zhao G. KLF9 aggravates the cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy through the lncRNA UCA1 /p27 axis. International Journal of Experimental Pathology. 2025. doi:10.1111/iep.12526

BibTeX
@article{Ding2025,
  author = {Ding, Dayou and Zhao, Guangrong},
  title = {KLF9 aggravates the cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy through the lncRNA UCA1 /p27 axis},
  journal = {International Journal of Experimental Pathology},
  year = {2025},
  doi = {10.1111/iep.12526}
}
Kostenlos starten →